Research ArticleClinical Investigation
Open Access
Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale and Frederik L. Giesel
Journal of Nuclear Medicine August 2023, 64 (8) 1225-1231; DOI: https://doi.org/10.2967/jnumed.123.265486
Tadashi Watabe
1Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Osaka, Japan;
2Institute for Radiation Sciences, Osaka University, Osaka, Japan;
Sadahiro Naka
3Department of Pharmacy, Osaka University Hospital, Osaka, Japan;
Mitsuaki Tatsumi
4Department of Radiology, Osaka University Hospital, Osaka, Japan;
Takashi Kamiya
4Department of Radiology, Osaka University Hospital, Osaka, Japan;
Toru Kimura
5Department of Thoracic Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Yasushi Shintani
5Department of Thoracic Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Kaori Abe
6Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Tomohiro Miyake
6Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Kenzo Shimazu
6Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Shogo Kobayashi
7Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Yukinori Kurokawa
7Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Hidetoshi Eguchi
7Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Yuichiro Doki
7Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan;
Hidenori Inohara
8Department of Otorhinolaryngology–Head and Neck Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan; and
Hiroki Kato
1Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Osaka, Japan;
2Institute for Radiation Sciences, Osaka University, Osaka, Japan;
Yuriko Mori
9Department of Nuclear Medicine, University Hospital Duesseldorf, Heinrich Heine University, Duesseldorf, Germany
Jens Cardinale
9Department of Nuclear Medicine, University Hospital Duesseldorf, Heinrich Heine University, Duesseldorf, Germany
Frederik L. Giesel
2Institute for Radiation Sciences, Osaka University, Osaka, Japan;
9Department of Nuclear Medicine, University Hospital Duesseldorf, Heinrich Heine University, Duesseldorf, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 64, Issue 8
August 1, 2023
Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale, Frederik L. Giesel
Journal of Nuclear Medicine Aug 2023, 64 (8) 1225-1231; DOI: 10.2967/jnumed.123.265486
Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale, Frederik L. Giesel
Journal of Nuclear Medicine Aug 2023, 64 (8) 1225-1231; DOI: 10.2967/jnumed.123.265486
Jump to section
Related Articles
Cited By...
- Fibroblast Activation Protein-Targeted PET/CT with 18F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18F-FDG PET/CT
- Immuno-PET and Targeted {alpha}-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma